124 related articles for article (PubMed ID: 36809539)
1. OASL knockdown inhibits the progression of stomach adenocarcinoma by regulating the mTORC1 signaling pathway.
Zhao W; Yang H; Liu L; Qu X; Ding J; Yu H; Xu B; Zhao S; Xi G; Xing L; Chai J
FASEB J; 2023 Mar; 37(3):e22824. PubMed ID: 36809539
[TBL] [Abstract][Full Text] [Related]
2. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
[TBL] [Abstract][Full Text] [Related]
3. ClC-3/SGK1 regulatory axis enhances the olaparib-induced antitumor effect in human stomach adenocarcinoma.
Gu Z; Wang L; Yao X; Long Q; Lee K; Li J; Yue D; Yang S; Liu Y; Li N; Li Y
Cell Death Dis; 2020 Oct; 11(10):898. PubMed ID: 33093458
[TBL] [Abstract][Full Text] [Related]
4. GPX3-Mediated Oxidative Stress Affects Pyrimidine Metabolism Levels in Stomach Adenocarcinoma via the AMPK/mTOR Pathway.
Zhang Y; Yang Y; Kuang S; Zhang Y; Qin H; Xie J
Int J Clin Pract; 2024; 2024():6875417. PubMed ID: 38322113
[TBL] [Abstract][Full Text] [Related]
5. CDCA7-regulated inflammatory mechanism through TLR4/NF-κB signaling pathway in stomach adenocarcinoma.
Guo Y; Zhou K; Zhuang X; Li J; Shen X
Biofactors; 2021 Sep; 47(5):865-878. PubMed ID: 34339079
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ITGB1-DT expression delays the growth and migration of stomach adenocarcinoma and improves the prognosis of cancer patients using the bioinformatics and cell model analysis.
Jiang N; Guo Q; Luo Q
J Gastrointest Oncol; 2022 Apr; 13(2):615-629. PubMed ID: 35557569
[TBL] [Abstract][Full Text] [Related]
7. FKBP10 functioned as a cancer-promoting factor mediates cell proliferation, invasion, and migration via regulating PI3K signaling pathway in stomach adenocarcinoma.
Wang RG; Zhang D; Zhao CH; Wang QL; Qu H; He QS
Kaohsiung J Med Sci; 2020 May; 36(5):311-317. PubMed ID: 31868996
[TBL] [Abstract][Full Text] [Related]
8. The Potential Role of IL1RAP on Tumor Microenvironment-Related Inflammatory Factors in Stomach Adenocarcinoma.
Lv Q; Xia Q; Li A; Wang Z
Technol Cancer Res Treat; 2021; 20():1533033821995282. PubMed ID: 33602046
[TBL] [Abstract][Full Text] [Related]
9. Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation.
Hibdon ES; Razumilava N; Keeley TM; Wong G; Solanki S; Shah YM; Samuelson LC
Neoplasia; 2019 Jul; 21(7):702-712. PubMed ID: 31129492
[TBL] [Abstract][Full Text] [Related]
10. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta gene as a tumour suppressor in stomach adenocarcinoma.
Li Y; Xiong JB; Jie ZG; Xiong H
Front Oncol; 2022; 12():1069875. PubMed ID: 36518312
[TBL] [Abstract][Full Text] [Related]
12. STAT4-mediated down-regulation of miR-3619-5p facilitates stomach adenocarcinoma by modulating TBC1D10B.
Liu Y; Li J; Wang S; Song H; Yu T
Cancer Biol Ther; 2020 Jul; 21(7):656-664. PubMed ID: 32397798
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of MicroRNA-375 Inhibits Proliferation and Migration in Gastric Cancer in Association With Autophagy-Mediated AKT/mTOR Signaling Pathways.
Yuan KT; Li BX; Yuan YJ; Tan M; Tan JF; Dai WG; Feng WD; Zuo JD
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806499. PubMed ID: 30355273
[TBL] [Abstract][Full Text] [Related]
14. Oligoadenylate-Synthetase-Family Protein OASL Inhibits Activity of the DNA Sensor cGAS during DNA Virus Infection to Limit Interferon Production.
Ghosh A; Shao L; Sampath P; Zhao B; Patel NV; Zhu J; Behl B; Parise RA; Beumer JH; O'Sullivan RJ; DeLuca NA; Thorne SH; Rathinam VAK; Li P; Sarkar SN
Immunity; 2019 Jan; 50(1):51-63.e5. PubMed ID: 30635239
[TBL] [Abstract][Full Text] [Related]
15. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.
Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S
Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398
[TBL] [Abstract][Full Text] [Related]
16. Interaction between the 2'-5' oligoadenylate synthetase-like protein p59 OASL and the transcriptional repressor methyl CpG-binding protein 1.
Andersen JB; Strandbygård DJ; Hartmann R; Justesen J
Eur J Biochem; 2004 Feb; 271(3):628-36. PubMed ID: 14728690
[TBL] [Abstract][Full Text] [Related]
17. FGL1 Promotes Tumor Immune Escape in Stomach Adenocarcinoma via the Notch Signaling Pathway.
Zhou Y; Liu D; Li H
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37902887
[TBL] [Abstract][Full Text] [Related]
18. TEAD4 activates PCSK9 to promote stomach adenocarcinoma cell stemness through fatty acid metabolism.
Xu D; Han G; Zhou X; Yong H; Jia Y; Zhao F; Shi H
Digestion; 2024 Apr; ():. PubMed ID: 38663369
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Bioinformatic Analysis of NOTCH Pathway Involvement in Stomach Adenocarcinoma.
Xue D; Li D; Dou C; Li J
Dis Markers; 2021; 2021():4739868. PubMed ID: 34925644
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor E2F3 activates CDC25B to regulate DNA damage and promote mitoxantrone resistance in stomach adenocarcinoma.
Pan X; Xu C; Cheng G; Chen Z; Liu M; Mei Y
Mol Biol Rep; 2024 Jan; 51(1):90. PubMed ID: 38194158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
